category
Nature BME
date
Mar 17, 2026
slug
status
Published
summary
开发了一种仿生平台(iMRAS),能够在体内局部招募、激活和扩增CAR-iNKT细胞,从而增强其抗肿瘤功能,提高癌症免疫治疗的效果。
tags
合成生物学
type
Post

📄 原文题目

Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy

🔗 原文链接

💡 AI 核心解读

开发了一种仿生平台(iMRAS),能够在体内局部招募、激活和扩增CAR-iNKT细胞,从而增强其抗肿瘤功能,提高癌症免疫治疗的效果。

📝 英文原版摘要

<p>Nature Biomedical Engineering, Published online: 17 March 2026; <a href="https://www.nature.com/articles/s41551-026-01629-3">doi:10.1038/s41551-026-01629-3</a></p>The iNKT cell-targeted microparticle recruitment and activation system (iMRAS) is a biomimetic platform that serves to locally recruit, activate and expand CAR-iNKT cells in vivo to enhance CAR-iNKT functionality for improved cancer immunotherapy.
具有‘三脚架状’结构的肺靶向(LuT)脂质用于高效且选择性的脂质纳米颗粒(LNPs)基因传递和编辑AlphaFold迈入新阶段:AI数据库现已包含蛋白质配对
Loading...